Search Within

Sujata Patil

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (13)
  2. Meeting Abstract (8)
Groups
  1. Biostatistics Service (21)
  2. Epidemiology and Biostatistics (21)
  3. GSK Faculty (21)
  4. Molecular Pharmacology and Chemistry Program Faculty (21)
  5. Sloan Kettering Institute Faculty (21)
  6. Department of Medicine (18)

More Groups

People
  1. Clifford Hudis (14)
  2. Shanu Modi (11)
  3. Steven Larson (9)
  4. Komal Jhaveri (8)
  5. Neal Rosen (8)
  6. Sarat Chandarlapaty (8)

More People

Years
  1. 2021 (1)
  2. 2020 (2)
  3. 2019 (2)
  4. 2016 (2)
  5. 2015 (1)
  6. 2013 (2)

More Years

Publications
  1. Journal of Clinical Oncology (5)
  2. Cancer Research (4)
  3. Clinical Cancer Research (3)
  4. Clinical Breast Cancer (2)
  5. Cancer (1)
  6. Cancer Medicine (1)

More Publications

Publishers
  1. American Association for Cancer Research (7)
  2. American Society of Clinical Oncology (6)
  3. Nature Publishing Group (3)
  4. Elsevier Inc. (2)
  5. Wiley Blackwell (2)
  6. Society of Nuclear Medicine (1)

Results (21)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I study of alpelisib in combination with trastuzumab and LJM716 in patients with PIK3CA-mutated HER2-positive metastatic breast cancer
    Journal Article

    Jhaveri, K.; Drago, J. Z.; Shah, P. D.; Wang, R.; Pareja, F.; Ratzon, F.; Iasonos, A.; Patil, S.; Rosen, N.; Fornier, M. N.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Measuring tumor epichaperome expression using [(124)I] PU-H71 positron emission tomography as a biomarker of response for PU-H71 plus nab-paclitaxel in HER2-negative metastatic breast cancer
    Journal Article

    Jhaveri, K. L.; dos Anjos, C. H.; Taldone, T.; Wang, R.; Comen, E.; Fornier, M.; Bromberg, J. F.; Ma, W.; Patil, S.; Rodina, A.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • The epichaperome is a mediator of toxic hippocampal stress and leads to protein connectivity-based dysfunction
    Journal Article

    Inda, M. C.; Joshi, S.; Wang, T.; Bolaender, A.; Gandu, S.; Koren, J. 3rd; Che, A. Y.; Taldone, T.; Yan, P.; Sun, W.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • A rectal cancer organoid platform to study individual responses to chemoradiation
    Journal Article

    Ganesh, K.; Wu, C.; O’Rourke, K. P.; Szeglin, B. C.; Zheng, Y.; Sauvé, C. E. G.; Adileh, M.; Wasserman, I.; Marco, M. R.; Kim, A. S.; more...
    Nature Medicine (2019)

    Fulltext@MSK | Save
  • Tumor epichaperome expression using (124)I PU-H71 PET (PU-PET) as a biomarker of response for PU-H71 plus nab-paclitaxel in HER2 negative (HER2-) metastatic breast cancer (MBC)
    Meeting Abstract

    Jhaveri, K.; Dunphy, M.; Wang, R.; Comen, E.; Fornier, M.; Moynahan, M. E.; Bromberg, J.; Ma, W.; Patil, S.; Taldone, T.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • The epichaperome is an integrated chaperome network that facilitates tumour survival
    Journal Article

    Rodina, A.; Wang, T.; Yan, P.; Gomes, E. D.; Dunphy, M. P. S.; Pillarsetty, N.; Koren, J. 3rd; Gerecitano, J. F.; Taldone, T.; Zong, H.; more...
    Nature (2016)

    Fulltext@MSK | Save
  • Biomarkers that predict sensitivity to heat shock protein 90 inhibitors
    Journal Article

    Jhaveri, K.; Chandarlapaty, S.; Iyengar, N.; Morris, P. G.; Corben, A. D.; Patil, S.; Akram, M.; Towers, R.; Sakr, R. A.; King, T. A.; more...
    Clinical Breast Cancer (2016)

    Fulltext@MSK | Save
  • A phase I/II study of neratinib plus temsirolimus in HER2+ metastatic breast cancer reveals ongoing HER2 pathway dependence in many patients despite several lines of HER2 targeted therapy
    Meeting Abstract

    Gajria, D.; Modi, S.; Saura, C.; Sakr, R.; Solano, K.; Won, H.; Pannu, H.; Patil, S.; Lake, D.; Traina, T.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer
    Journal Article

    Ulaner, G. A.; Eaton, A.; Morris, P. G.; Lilienstein, J.; Jhaveri, K.; Patil, S.; Fazio, M.; Larson, S.; Hudis, C. A.; Jochelson, M. S.
    Cancer Medicine (2013)

    Fulltext@MSK | Save
  • Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancer
    Journal Article

    Gemignani, M. L.; Patil, S.; Seshan, V. E.; Sampson, M.; Humm, J. L.; Lewis, J. S.; Brogi, E.; Larson, S. M.; Morrow, M.; Pandit-Taskar, N.
    Journal of Nuclear Medicine (2013)

    Fulltext@MSK | Save